KR20010062277A - A functional tea composition having anti-stress effect - Google Patents
A functional tea composition having anti-stress effect Download PDFInfo
- Publication number
- KR20010062277A KR20010062277A KR1020000074711A KR20000074711A KR20010062277A KR 20010062277 A KR20010062277 A KR 20010062277A KR 1020000074711 A KR1020000074711 A KR 1020000074711A KR 20000074711 A KR20000074711 A KR 20000074711A KR 20010062277 A KR20010062277 A KR 20010062277A
- Authority
- KR
- South Korea
- Prior art keywords
- stress
- effect
- weight
- raw material
- john
- Prior art date
Links
- 230000002180 anti-stress Effects 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 230000000694 effects Effects 0.000 title abstract description 39
- 235000020542 functional tea Nutrition 0.000 title abstract description 6
- 244000269722 Thea sinensis Species 0.000 claims abstract description 20
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 13
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 13
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 13
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 13
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims abstract description 11
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims abstract description 11
- 235000009569 green tea Nutrition 0.000 claims abstract description 10
- 244000126014 Valeriana officinalis Species 0.000 claims abstract description 9
- 235000013832 Valeriana officinalis Nutrition 0.000 claims abstract description 9
- 235000016788 valerian Nutrition 0.000 claims abstract description 9
- 235000011925 Passiflora alata Nutrition 0.000 claims abstract description 8
- 235000000370 Passiflora edulis Nutrition 0.000 claims abstract description 8
- 235000011922 Passiflora incarnata Nutrition 0.000 claims abstract description 8
- 235000013750 Passiflora mixta Nutrition 0.000 claims abstract description 8
- 235000013731 Passiflora van volxemii Nutrition 0.000 claims abstract description 8
- 244000042664 Matricaria chamomilla Species 0.000 claims abstract 2
- 244000141009 Hypericum perforatum Species 0.000 claims description 15
- 235000017309 Hypericum perforatum Nutrition 0.000 claims description 15
- 240000008440 Passiflora incarnata Species 0.000 claims description 4
- 241001632410 Eleutherococcus senticosus Species 0.000 claims description 3
- 244000178231 Rosmarinus officinalis Species 0.000 abstract description 12
- 244000178870 Lavandula angustifolia Species 0.000 abstract description 10
- 235000010663 Lavandula angustifolia Nutrition 0.000 abstract description 10
- 239000001102 lavandula vera Substances 0.000 abstract description 10
- 235000018219 lavender Nutrition 0.000 abstract description 10
- 208000019901 Anxiety disease Diseases 0.000 abstract description 6
- 230000036506 anxiety Effects 0.000 abstract description 5
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract description 4
- 240000002690 Passiflora mixta Species 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 3
- 241001529735 Melissa Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 208000010643 digestive system disease Diseases 0.000 abstract 1
- 208000018685 gastrointestinal system disease Diseases 0.000 abstract 1
- 235000008434 ginseng Nutrition 0.000 abstract 1
- 239000002994 raw material Substances 0.000 description 23
- 230000035882 stress Effects 0.000 description 15
- 235000013616 tea Nutrition 0.000 description 11
- 240000003538 Chamaemelum nobile Species 0.000 description 10
- 244000062730 Melissa officinalis Species 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000002245 particle Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000002438 stress hormone Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 235000010654 Melissa officinalis Nutrition 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 240000001439 Opuntia Species 0.000 description 2
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000002249 anxiolytic agent Substances 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 244000208874 Althaea officinalis Species 0.000 description 1
- 235000006576 Althaea officinalis Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010017886 Gastroduodenal ulcer Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010027951 Mood swings Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000109365 Rosa arkansana Species 0.000 description 1
- 235000005066 Rosa arkansana Nutrition 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010043268 Tension Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000037328 acute stress Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- -1 anti-cancer Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 235000016520 artichoke thistle Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000020346 chamomile tea Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000001814 effect on stress Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 231100000029 gastro-duodenal ulcer Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 239000008361 herbal raw material Substances 0.000 description 1
- 235000015092 herbal tea Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- DATAGRPVKZEWHA-UHFFFAOYSA-N l-theanine Chemical compound CCNC(=O)CCC(N)C(O)=O DATAGRPVKZEWHA-UHFFFAOYSA-N 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 235000001035 marshmallow Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 208000019906 panic disease Diseases 0.000 description 1
- 210000001369 pituitary-adrenal system Anatomy 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
- B65D85/70—Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for
- B65D85/804—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package
- B65D85/808—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package for immersion in the liquid to release part or all of their contents, e.g. tea bags
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/214—Tea
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 항스트레스 효과가 있는 다류 조성물에 관한 것으로, 더욱 상세하게는 세인트존스워트(St. John's wort), 녹차(green tea), 카모마일(chamomile), 가시오가피(Siberian Ginseng), 쥐오줌풀(valerian root), 패션플라워(passion flower), 라벤더(lavender), 페퍼민트(peppermint), 멜리사(melissa), 로즈마리(rosemary) 및 로즈힙(rosehip)으로 이루어진 군에서 선택된 1종 이상으로 함유하는 것을 특징으로 하는 항스트레스 효과를 갖는 기능성 다류 조성물에 관한 것이다.The present invention relates to a multi-veget composition with an anti-stress effect, and more particularly, St. John's wort, green tea, chamomile, Siberian Ginseng, Valerian root ), Passion flower, lavender (lavender), peppermint (peppermint), Melissa (melissa), rosemary (rosemary) and rosehip (rosehip) antistress characterized in that it contains one or more selected from the group consisting of A functional multi-flow composition having an effect.
스트레스를 유발하는 원인과 그로 인한 인체 내 생리적 변화는 다양하지만, 공통적으로 뇌하수체-부신계를 자극하여 스트레스 호르몬이 분비되고, 이러한 스트레스가 지속되면 인체의 기능이 저하되어 신경과민, 두통, 소화불량 등의 증상을 유발하며, 이것이 위십이지장궤양, 고혈압, 과민성대장염, 협심증 등의 2차 질병으로 발전된다. 특히 인스턴트 및 합성식품첨가물을 많이 섭취하는 현대인들은 스트레스성 위장장해로 고생하며, 또한 면역력이 저하되어 쉽게 피로해지고 감기에도자주 걸리는 등의 스트레스의 위해를 느끼게 된다.The causes of stress and the physiological changes in the human body are diverse, but stress hormones are secreted by stimulating the pituitary-adrenal system in common, and if the stress persists, the body's function decreases, such as nervousness, headache, and indigestion. It causes symptoms, which develop into secondary diseases such as gastroduodenal ulcer, hypertension, irritable colitis, and angina pectoris. In particular, modern people who consume a lot of instant and synthetic food additives suffer from stressful gastrointestinal disorders, and also suffer from stresses such as fatigue and frequent colds due to reduced immunity.
스트레스가 과도하게 부과되고 있는 현대사회에서 심신의 불안과 긴장을 완화하기 위한 제품이 절실히 요구되고 있으나, 심한 급성 스트레스나 심리적 충격으로 야기된 범불안장애, 공황장애 등의 정신과적 치료를 위해 병원에서 사용하는 항불안제, 항우울제, 진정제 등의 약물 이외에는 일반인들의 스트레스 완화에 쓰일 수 있는 제품은 없는 실정이다.In today's society where stress is excessively demanded, there is an urgent need for products to alleviate anxiety and tension of the mind and body, but in the hospital for psychiatric treatment such as general anxiety disorder and panic disorder caused by severe acute stress or psychological shock. There are no products that can be used to relieve stress of the general public other than drugs such as anti-anxiety agents, antidepressants, and sedatives used.
따라서, 일반인들을 대상으로 스트레스에 전반적인 효과가 있는 기능성 식품의 개발이 요구되고 있다. 현재 항스트레스 효과가 있는 건강식품이나 음료 등이 개발되어 판매되고 있긴 하지만, 음용에 거부감이 없고 기호성이 우수하며 평상시에 쉽게 접할 수 있는 다류의 개발이 요청되고 있는 실정이다.Therefore, the development of functional foods having an overall effect on stress is required for the general public. Currently, health foods and beverages with anti-stress effects have been developed and sold, but there is a demand for development of a variety of teas that have no objection to drinking, excellent palatability, and easy access to everyday life.
이에, 본 발명자들은 예로부터 다류의 재료가 되는 천연물들을 대상으로 항스트레스 효과를 측정한 결과, 세인트존스워트, 녹차, 카모마일, 가시오가피, 쥐오줌풀, 패션플라워, 라벤더, 페퍼민트, 멜리사, 로즈마리 및 로즈힙이 우수한 항스트레스 효과를 나타내는 것을 발견하고 본 발명을 완성하게 되었다.Thus, the present inventors have measured the anti-stress effect of natural products that are a variety of ingredients from the past, St. John's wort, green tea, chamomile, prickly pear, valerian, passion flower, lavender, peppermint, melissa, rosemary and rosehip The present invention has been found to exhibit excellent antistress effects.
본 발명의 목적은 항스트레스 효과가 뛰어난 기능성 다류의 조성물을 제공하는 것이다.An object of the present invention is to provide a functional polyclass composition having an excellent antistress effect.
상기한 본 발명의 목적, 그 외의 목적, 특징 및 장점은 하기 발명의 상세한 설명으로부터 당업자에게 명백하게 드러날 것이다.The above and other objects, features and advantages of the present invention will become apparent to those skilled in the art from the following detailed description.
상기한 목적을 달성하기 위하여, 본 발명의 항스트레스 효과를 갖는 기능성 다류 조성물은 세인트존스워트, 카모마일, 가시오가피, 쥐오줌풀, 패션플라워, 라벤더, 페퍼민트, 멜리사, 로즈마리 및 로즈힙으로 이루어진 군에서 선택된 1종 이상을 조성물 총 중량에 대하여 1~80중량%의 양으로 함유하는 것을 특징으로 한다.In order to achieve the above object, the functional tea composition having an anti-stress effect of the present invention is one species selected from the group consisting of St. John's wort, chamomile, prickly pear, Valerian, Passionflower, Lavender, Peppermint, Melissa, Rosemary and Rosehip It is characterized by containing the above in an amount of 1 to 80% by weight based on the total weight of the composition.
이하 본 발명을 더욱 상세하게 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명은 다류의 원료로 사용될 수 있고, 심신의 긴장이나 불안상태를 완화시켜주는 효능을 갖는 천연물들에 대하여 항스트레스 효과를 측정한 결과, 세인트존스워트, 카모마일, 가시오가피, 쥐오줌풀, 패션플라워, 라벤다, 페퍼민트, 멜리사, 로즈마리 및 로즈힙이 항스트레스 효과가 우수함을 발견하고, 이를 함유하는 기능성 다류를 제공하는 것이다.The present invention can be used as a variety of raw materials, the anti-stress effect is measured for natural products having the effect of relieving tension and anxiety of the mind and body, St. John's wort, chamomile, thorny stem, valerian, passion flower, Lavender, Peppermint, Melissa, Rosemary and Rosehip are found to be excellent in antistress effects and provide functional teas containing them.
본 발명의 조성물에 함유되는 성분의 특성을 설명하면 다음과 같다.The characteristic of the component contained in the composition of this invention is as follows.
본 발명에서 사용된 성분 중 세인트존스워트(St. John's wort)는 정신을 안정시키고, 우울증을 치료하는데 사용되어 왔을 뿐만 아니라 불면, 불안, 궤양과 위염, 신장의 질병에도 효과적으로 사용되어 온 허브이다.St. John's wort among the ingredients used in the present invention is a herb that has been used to stabilize the mind and to treat depression, as well as to sleep, anxiety, ulcers and gastritis, and diseases of the kidneys.
녹차(Green Tea)는 녹차의 카테킨 성분 때문에 항산화 작용을 비롯하여 항암, 항당뇨병, 항균작용, 소취작용 등의 효능이 있고, 또한 L-데아닌(L-theanin) 성분으로 인한 긴장완화(relaxation)효과로 스트레스에 효과가 있는 허브이다.Green Tea has the effects of antioxidant, anti-cancer, anti-diabetic, antibacterial and deodorizing effects due to the catechin component of green tea, and the relaxation effect of L-theanin. It is a herb that is effective against stress.
카모마일(chamomile)은 저염증, 방부, 구충약, 경련을 가라앉히는데 좋으며, 냉증이 있는 사람에게는 몸을 보온하는 효과가 있다. 또한, 카모마일 향은 스트레스 호르몬 분비와 관계된 부신피질자극호르몬(ACTH)을 감소시켜 마음이 초조하거나화가 나는 등의 심한 정신적 긴장을 완화시키는 효과가 있는 허브이다.Chamomile is good for calming hypo-inflammatory, antiseptic, antiparasitic medicines and cramps, and has a warming effect on people with cold symptoms. In addition, chamomile fragrance is a herb that has the effect of relieving severe mental tension, such as irritating or angry by reducing the corticosteroid hormone (ACTH) associated with stress hormone secretion.
로즈마리(rosemary)는 차로 만들어 마시면 원기 회복의 효과가 있으며, 소화불량, 항균작용, 혈액 순환 촉진 등에 도움이 되며, 침출액은 두통에 약효가 있어 흡입법으로 이용하면 뛰어난 효과를 볼 수 있는 허브이다.Rosemary (rosemary) is made of tea and refreshing effect, it helps with indigestion, antibacterial action, promote blood circulation, and leaching solution is effective for headache because it is effective for inhalation.
라벤더(Lavender)는 차로 마시면 진정작용에 효과가 있으며, 진통 효과가 있고, 두통을 없애 주며, 기분을 전환시켜 숙면과 피로 회복에 도움을 주는 허브이다.Lavender is a herb that is effective in sedation, pain relief, headaches, and mood swings.
쥐오줌풀(valerian root)은 전통적으로 수면 유도를 위해 사용되어온 약용식물로서, 중추신경계의 안정 및 진정효과를 나타내는 허브이다.Valerian root is a medicinal plant that has traditionally been used for induction of sleep and is a herb that has a stable and calming effect on the central nervous system.
패션플라워(passion flower)는 항불안, 진정작용이 있는 허브이다.Passion flower is an anti-anxiety and soothing herb.
가시오가피(Siberian ginseng)는 진정작용이 매우 강한 약효 물질로, 특히 예방 의학적인 효과와 기타 스트레스에 대한 저항 또는 상쇄효과가 대단히 큰 허브이다.Siberian ginseng is a highly sedative drug, particularly a herb with a prophylactic and other resistance to stress or a great offsetting effect.
페퍼민트(Peppermint)는 두통, 히스테리, 신경통 등에 사용되는 허브이다.Peppermint is a herb used in headaches, hysteria and neuralgia.
멜리사(Melissa, 레몬밤)의 잎으로 만든 허브차는 머리를 맑게 하고, 우울증에 효과적으로 사용되며 정신을 안정시키는 진정효과가 있으며 피로회복에 탁월한 효과가 있는 허브이다.Herbal tea made from the leaves of Melissa (lemon balm) is a herb that clears the head, is used effectively for depression, has a calming effect that calms the mind, and is excellent for fatigue recovery.
로즈힙(rosehip)은 들장미의 열매인데, 비타민C, A, B, E, K, 니코틴산, 유기산, 탄닌 등이 골고루 함유되어 있으며 특히 비타민C가 풍부하여 부족되기 쉬운 비타민C를 보충할 수 있는 허브이다.Rosehip is a fruit of wild rose, which contains vitamin C, A, B, E, K, nicotinic acid, organic acid, and tannin evenly. Especially, it is a herb that can supplement vitamin C which is easy to lack due to abundant vitamin C. .
본 발명에 따른 항스트레스 효과를 갖는 다류 조성물은 상기한 효능 및 효과를 갖는 원료를 1~80중량%의 양으로 함유하는 것이 바람직하다. 이는 원료의 함량이 1중량% 미만이면 목적하는 항스트레스 효과를 얻을 수 없고, 80중량%를 초과하는 경우에는 맛과 향 등의 기호성에 있어서 문제시 되기 때문이다.It is preferable that the multi-class composition which has an antistress effect which concerns on this invention contains the raw material which has the above-mentioned efficacy and effects in the quantity of 1 to 80 weight%. This is because, if the content of the raw material is less than 1% by weight, the desired antistress effect cannot be obtained, and if it exceeds 80% by weight, there is a problem in palatability such as taste and aroma.
본 발명의 기능성 다류 조성물은 차, 티백, 음료 등으로 제형화될 수 있으며, 상기한 성분이외에 다른 성분은 제형에 따라 당업자가 적의하게 선택하여 배합할 수 있다.Functional functional tea composition of the present invention can be formulated as tea, tea bags, beverages and the like, other components than the above components can be appropriately selected and blended by those skilled in the art according to the formulation.
<시험예 1> 각 원료의 항스트레스 효과<Test Example 1> anti-stress effect of each raw material
상기 각 원료의 항스트레스 효과를 평가하기 위하여 체중 약 200g 안팎의 랫트를 이용하여 실험하였다. 각 원료를 마쇄하여 80℃의 온수 100㎖에 5g 투입 후 10분간 추출하고 여과한 후 동결건조하여 추출물을 준비하였다. 실험군은 음성대조군(스트레스를 부과하지 않은 군), 스트레스 부과군(구속 스트레스 부과용의 20x30cm 크기 아크릴판에 랫트의 사지를 묶어 일정시간 고정시킨다), 원료의 추출물 투여군으로 나누었다. 각 원료의 추출물은 체중에 따라 환산하여 1주일간 1일 1회, 스트레스 부가 전후 2시간 간격으로 경구투여하고, 구속 스트레스를 18시간 부과한 후 부검하였다. 스트레스 지표로서 위장장해(위장 점막의 혈흔 측정), 부신의 무게, 비장의 무게, 스트레스호르몬(corticosterone)을 측정하고, 그에 따른 스트레스효과를 하기 수학식 1에 따라 계산하여 그 결과를 아래 표 1에 나타내었다(단, 군 당 개체 수는 8마리이고, 허브 추출물 투여량은 500mg/kg으로 하였다).In order to evaluate the anti-stress effect of each raw material, experiments were performed using rats of about 200 g body weight. Each raw material was ground and 5g was poured into 100 ml of 80 ° C. hot water, followed by extraction for 10 minutes, filtered, and lyophilized to prepare an extract. The experimental group was divided into a negative control group (not stressed group), a stressed group (fixed rat's limbs in a 20x30cm size acrylic plate for restraint stress immobilization for a fixed time), and the extract administration group of the raw material. The extract of each raw material was orally administered once a week for 1 week, 2 hours before and after stress addition, and subjected to restraint stress for 18 hours. Gastrointestinal disorders (measures of blood in the gastrointestinal mucosa), adrenal gland weights, spleen weights, and stress hormones (corticosterone) were measured as stress indicators, and the resulting stress effects were calculated according to Equation 1 below. (However, the number of individuals per group is 8, the herbal extract dose was set to 500 mg / kg).
천연물 원료의 항스트레스 효과를 평가한 결과, 부신의 비대함이 현저히 방어되었고, 면역계와 관계 있는 것으로 알려진 비장의 무게는 정상 수준은 아니었지만 장기의 위축이 현저히 진행되지는 않은 것으로 나타났다. 상기 표 1로부터 알 수 있듯이, 본 발명의 조성물에 함유되는 원료는 여러 종류의 천연물 원료들 중에서 우수한 우수한 항스트레스 효과가 있는 천연물을 선택했다.Evaluation of the antistress effect of natural ingredients showed that the adrenal hypertrophy was significantly defended, and the spleen, which was known to be related to the immune system, was not normal, but organ contraction did not progress significantly. As can be seen from Table 1, the raw material contained in the composition of the present invention selected a natural product having an excellent anti-stress effect among various kinds of natural raw materials.
<시험예 2> 각 원료 혼합시의 항스트레스 효과 측정<Test Example 2> Anti-stress effect measurement at the time of mixing each raw material
각 원료를 혼합한 후 실험예1과 동일한 방법으로 항스트레스 효과를 측정하여 표 2에 나타냈다.After mixing each raw material, the anti-stress effect was measured in the same manner as in Experimental Example 1 and shown in Table 2.
한편, 상기 표2 와 같이 원료 단독보다는 두가지 이상의 원료를 혼합한 것이 효과가 우수하였으며, 특히 세인트존스워트와 녹차 또는 세인트존스워트와 로즈마리 혼합물에 다른 원료를 1종 이상 혼합하였을 때 나타날 수 있는 상승효과(synergy effect) 가능성을 확인하기 위하여 위와 같이 각 허브 원료를 혼합하여 표1의 항스트레스 지표로서 이들의 항스트레스 효과 평균을 측정한 결과 세인트존스워트와 로즈마리 혼합물에 카모마일, 라벤다, 페퍼민트, 로즈힙을 혼합한 경우 항스트레스 상승 효과가 가장 컸다.On the other hand, as shown in Table 2, the effect of mixing two or more raw materials than the raw material alone was excellent, in particular, synergistic effects that may occur when one or more other ingredients are mixed in St. John's wort and green tea or St. John's wort and rosemary mixture. In order to confirm the possibility of synergy effect, each herbal raw material was mixed as above and the average of the antistress effect was measured as the anti-stress index of Table 1. In one case, the antistress synergy was the greatest.
이하 본 발명에 따른 항스트레스 효과가 있는 기능성 다류 조성물을 실시예를 들어 설명한다.Hereinafter, a functional multiflow composition having an antistress effect according to the present invention will be described with reference to Examples.
<실시예 1><Example 1>
세인트존스워트를 수분함량이 10% 이하가 되도록 충분히 건조한 후 마쇄기를 이용하여 입자크기가 0.5-3㎜가 되도록 마쇄한 다음, 이를 1.0g 티백으로 제조한다.St. John's wort is sufficiently dried to have a water content of 10% or less, and then ground to a particle size of 0.5-3 mm using a grinding machine, and then 1.0 g tea bags are prepared.
<실시예 2><Example 2>
세인트존스워트, 녹차를 수분함량이 10% 이하가 되도록 충분히 건조한 후 마쇄기를 이용하여 입자크기가 0.5-3㎜가 되도록 마쇄한다. 각 원료의 비율이 30:20 중량비가 되도록 혼합한 후, 1.0g 티백으로 제조한다.St. John's wort and green tea are sufficiently dried to have a water content of 10% or less, and then ground to a particle size of 0.5-3 mm using a grinding machine. After mixing so that the ratio of each raw material may be 30:20 weight ratio, it manufactures with 1.0g tea bag.
<실시예 3><Example 3>
세인트존스워트, 녹차를 수분함량이 10% 이하가 되도록 충분히 건조한 후 마쇄기를 이용하여 입자크기가 0.5-3㎜ 되도록 마쇄한다. 각 원료의 비율이 30:20이 되도록 혼합하여 준비한다. 혼합원료 80중량%에 가시오가피 10중량%, 쥐오줌풀 10 중량%로 혼합하여 1.0g 티백으로 제조한다.St. John's wort and green tea are sufficiently dried to have a water content of 10% or less, and then ground to a particle size of 0.5-3 mm using a grinding machine. Prepare by mixing so that the ratio of each raw material may be 30:20. It is mixed with 80% by weight of the mixed raw materials 10% by weight, 10% by weight of Valerian grass to prepare a 1.0g tea bag.
<실시예 4><Example 4>
세인트존스워트, 카모마일, 녹차를 수분함량이 10% 이하가 되도록 충분히 건조한후 마쇄기를 이용하여 입자크기가 0.5-3㎜ 되도록 마쇄한다. 각 원료의 비율이 30:20:20이 되도록 혼합하여 준비한다. 혼합원료 80중량%에 페퍼민트 10중량%, 멜리사5%, 로즈마리5중량%로 혼합하여 1.0g 티백으로 제조한다.St. John's wort, chamomile, and green tea are sufficiently dried to have a water content of 10% or less, and then ground to a particle size of 0.5-3 mm using a grinding machine. Prepare by mixing so that the ratio of each raw material is 30:20:20. Mixing 80% by weight of peppermint 10% by weight, Melissa 5%, rosemary 5% by weight to prepare a 1.0g tea bag.
<실시예 5>Example 5
세인트존스워트, 패션플라워, 라벤다, 녹차를 수분함량이 10% 이하가 되도록 충분히 건조한 후 마쇄기를 이용하여 입자크기가 0.5-3㎜ 되도록 마쇄한다. 각 원료의 비율이 30:10:10:20이 되도록 혼합하여 준비한다. 혼합원료 80중량%에 페퍼민트 10중량%, 멜리사5%, 로즈마리 5중량%로 혼합하여 1.0g 티백으로 제조한다.St. John's wort, Passion Flower, Lavender, and Green Tea are sufficiently dried to have a water content of 10% or less, and then ground to a particle size of 0.5-3㎜ using a grinding machine. Prepare by mixing so that the ratio of each raw material is 30: 10: 10: 20. It is mixed with 80% by weight of raw material peppermint 10% by weight, Melissa 5%, rosemary 5% by weight to prepare a 1.0g tea bag.
<실시예 6><Example 6>
세인트존스워트, 로즈마리, 로즈힙을 수분함량이 10% 이하가 되도록 충분히 건조한 후 마쇄기를 이용하여 입자크기가 0.5-3㎜ 되도록 마쇄한다. 각 원료의 비율이 10:50:20이 되도록 혼합하여 준비한다. 혼합원료 80중량%에 페퍼민트 5중량%, 카모마일10%, 라벤다5중량%로 혼합하여 1.0g 티백으로 제조한다.St. John's wort, rosemary, and rosehip are sufficiently dried to have a water content of 10% or less, and then ground to a particle size of 0.5-3 mm using a grinding machine. Prepare by mixing so that the ratio of each raw material is 10:50:20. The mixture is mixed with 80% by weight of peppermint 5% by weight, chamomile 10%, and lavender 5% by weight to prepare 1.0 g tea bags.
<실시예 7><Example 7>
로즈마리, 라벤다, 카모마일, 페퍼민트를 수분함량이 10% 이하가 되도록 충분히 건조한 후 마쇄기를 이용하여 입자크기가 0.5-3㎜ 되도록 마쇄한다. 각 원료의 비율이 50:10:10:10이 되도록 혼합하여 준비한다. 혼합원료 80중량%에 로즈힙 20중량%로 혼합하여 1.0g 티백으로 제조한다.Rosemary, lavender, chamomile, and peppermint are dried sufficiently to have a water content of 10% or less, and then ground to a particle size of 0.5-3 mm using a grinding machine. Mix and prepare so that the ratio of each raw material may be 50: 10: 10: 10. 80% by weight of the mixed raw material to 20% by weight of the rosehip to prepare a 1.0g tea bag.
실시예에 따라 제조된 다류 조성물을 이용하여 항스트레스 효과를 확인한 결과는 다음과 같다.The results of confirming the anti-stress effect using the multi-flow composition prepared according to the embodiment are as follows.
이상에서 설명한 바와 같이, 본 발명의 다류 조성물은 스트레스로 인한 심신의 불안과 긴장을 완화시키고, 스트레스에 의해 유발되는 위장장해와 면역력의 저하를 억제하는 항스트레스 효과를 제공할 수 있다.As described above, the present composition of the present invention may provide an anti-stress effect to alleviate anxiety and tension of the mind and body due to stress, and to suppress gastrointestinal disorders and lowering of immunity caused by stress.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0074711A KR100372783B1 (en) | 1999-12-08 | 2000-12-08 | A functional tea composition having anti-stress effect |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990055702 | 1999-12-08 | ||
KR19990055702 | 1999-12-08 | ||
KR10-2000-0074711A KR100372783B1 (en) | 1999-12-08 | 2000-12-08 | A functional tea composition having anti-stress effect |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010062277A true KR20010062277A (en) | 2001-07-07 |
KR100372783B1 KR100372783B1 (en) | 2003-02-15 |
Family
ID=26636416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2000-0074711A KR100372783B1 (en) | 1999-12-08 | 2000-12-08 | A functional tea composition having anti-stress effect |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100372783B1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100713685B1 (en) * | 2005-06-28 | 2007-05-02 | (주)상수허브랜드 | Herb green tea which has exellent flavor and anti-cancer activity |
EP1925313A1 (en) * | 2006-11-24 | 2008-05-28 | Nestec S.A. | Prevention and treatment of disorders connected to impaired neurotransmission |
EP1925302A1 (en) * | 2006-11-24 | 2008-05-28 | DSMIP Assets B.V. | Dietary or pharmaceutical compositions containing tricyclic diterpenes and derivatives thereof for the treatment of depression |
WO2008061757A1 (en) * | 2006-11-24 | 2008-05-29 | Dsm Ip Assets B.V. | Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses |
WO2009015454A1 (en) * | 2007-07-31 | 2009-02-05 | Sandra Maria Salles Hanszmann | Composition and manufacturing process of calming and sleep facilitator product |
CN102349587A (en) * | 2011-10-20 | 2012-02-15 | 陈雨婷 | Lavender fruit-flavored tea |
KR101337895B1 (en) * | 2007-10-18 | 2013-12-09 | (주)아모레퍼시픽 | Mixed cherry-flavored green tea with excellent preference and the method for manufacturing thereof |
KR101493317B1 (en) * | 2008-05-23 | 2015-02-16 | (주)아모레퍼시픽 | Daily tea with excellent preference and the method preparing thereof |
KR20160063552A (en) * | 2014-11-26 | 2016-06-07 | 고려대학교 산학협력단 | Composition for promoting sleep including hop extract |
KR20220051721A (en) * | 2020-10-19 | 2022-04-26 | 재단법인 전남바이오산업진흥원 | Medi-food composition for induce deep sleep |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180084201A (en) | 2017-01-16 | 2018-07-25 | 주식회사 더큰프라임 | Medicinal herbal extract |
KR101982811B1 (en) | 2018-09-20 | 2019-05-29 | 주식회사 비앤에이치랩 | Composition for relieving stress |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62257344A (en) * | 1986-04-28 | 1987-11-09 | Tetsuyoshi Fukuoka | Herb-mixed green tea |
CN1088393A (en) * | 1992-12-24 | 1994-06-29 | 沈在中 | The processing method of tea of throat care |
KR20000006979A (en) * | 1999-11-12 | 2000-02-07 | 류종원 | Composition of tea mixed herbs |
KR20000006978A (en) * | 1999-11-12 | 2000-02-07 | 류종원 | Composition of tea mixed green tea, oat and herbs. |
KR101088393B1 (en) * | 2011-10-21 | 2011-12-01 | 주식회사 제이디티 | Cutting body for pipe cutting device |
-
2000
- 2000-12-08 KR KR10-2000-0074711A patent/KR100372783B1/en active IP Right Grant
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100713685B1 (en) * | 2005-06-28 | 2007-05-02 | (주)상수허브랜드 | Herb green tea which has exellent flavor and anti-cancer activity |
US20100233303A1 (en) * | 2006-11-24 | 2010-09-16 | Nestec S.A. | Prevention and treatment of disorders connected to impaired neurotransmission |
JP2010509925A (en) * | 2006-11-24 | 2010-04-02 | ディーエスエム アイピー アセッツ ビー.ブイ. | Food or pharmaceutical composition containing tricyclic diterpenes and derivatives thereof for the treatment of depression |
JP2010510293A (en) * | 2006-11-24 | 2010-04-02 | ネステク ソシエテ アノニム | Prevention and treatment of disorders related to neurotransmission disorders |
WO2008061754A1 (en) * | 2006-11-24 | 2008-05-29 | Dsm Ip Assets B.V. | Dietary or pharmaceutical compositions containing tricyclic diterpenes and derivatives thereof for the treatment of depression |
WO2008061757A1 (en) * | 2006-11-24 | 2008-05-29 | Dsm Ip Assets B.V. | Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses |
EP1930019A1 (en) * | 2006-11-24 | 2008-06-11 | DSMIP Assets B.V. | Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses |
EP1925302A1 (en) * | 2006-11-24 | 2008-05-28 | DSMIP Assets B.V. | Dietary or pharmaceutical compositions containing tricyclic diterpenes and derivatives thereof for the treatment of depression |
US8748491B2 (en) | 2006-11-24 | 2014-06-10 | Dsm Ip Assets B.V. | Dietary and pharmaceutical compositions containing tricyclic diterpenes and their derivatives and their uses |
WO2008062046A1 (en) * | 2006-11-24 | 2008-05-29 | Nestec S.A. | Prevention and treatment of disorders connected to impaired neurotransmission |
EP1925313A1 (en) * | 2006-11-24 | 2008-05-28 | Nestec S.A. | Prevention and treatment of disorders connected to impaired neurotransmission |
RU2455017C2 (en) * | 2006-11-24 | 2012-07-10 | Нестек С.А. | Prevention and treatment of disorders associated with disturbed neurotransmission |
KR101520505B1 (en) * | 2006-11-24 | 2015-05-18 | 네스텍 소시에테아노님 | Prevention and treatment of disorders connected to impaired neurotransmission |
US8552055B2 (en) | 2006-11-24 | 2013-10-08 | Dsm Ip Assets B.V. | Dietary and pharmaceutical compositions containing tricyclic diterpenes and their derivates and their uses |
WO2009015454A1 (en) * | 2007-07-31 | 2009-02-05 | Sandra Maria Salles Hanszmann | Composition and manufacturing process of calming and sleep facilitator product |
KR101337895B1 (en) * | 2007-10-18 | 2013-12-09 | (주)아모레퍼시픽 | Mixed cherry-flavored green tea with excellent preference and the method for manufacturing thereof |
KR101493317B1 (en) * | 2008-05-23 | 2015-02-16 | (주)아모레퍼시픽 | Daily tea with excellent preference and the method preparing thereof |
CN102349587A (en) * | 2011-10-20 | 2012-02-15 | 陈雨婷 | Lavender fruit-flavored tea |
KR20160063552A (en) * | 2014-11-26 | 2016-06-07 | 고려대학교 산학협력단 | Composition for promoting sleep including hop extract |
KR20220051721A (en) * | 2020-10-19 | 2022-04-26 | 재단법인 전남바이오산업진흥원 | Medi-food composition for induce deep sleep |
Also Published As
Publication number | Publication date |
---|---|
KR100372783B1 (en) | 2003-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Di Lorenzo et al. | Adverse effects of plant food supplements and botanical preparations: a systematic review with critical evaluation of causality | |
CA2600301A1 (en) | Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition | |
US9220741B2 (en) | Weight loss formulation | |
KR100372783B1 (en) | A functional tea composition having anti-stress effect | |
CA2564326A1 (en) | Nutritional composition which promotes weight loss, burns calories, increases thermogenesis, supports energy metabolism and/or suppresses appetite | |
US20030143291A1 (en) | Herbal compositions and methods for diabetes and weight loss management. | |
US20060210653A1 (en) | Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition | |
CN105104635A (en) | Composite cyclocarya paliurus tea, and preparation method thereof | |
KR20130004675U (en) | Tea bag containing cucurbit seeds | |
CN101543248A (en) | A cold tea especially suitable for 'three high and one acid' population and method for its prepairing | |
US7943183B2 (en) | Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition | |
KR101291338B1 (en) | Use of lavender oil for the prophylaxis and treatment of neuro asthenia, somatization disorders and other diseases associated with stress | |
CN102552566A (en) | Oil-in-water type compound cinnamon oil nanoemulsion weight loosing preparation and preparation method thereof | |
WO2011054310A1 (en) | Tieguanyin healthcare tea | |
US20190160126A1 (en) | Compositions and methods for treating reproductive indicators symptomatic of male infertility | |
CA2751218C (en) | Weight loss formulation | |
KR0160402B1 (en) | Composition for prevention of stress | |
RU2612145C1 (en) | F.n. volkov's herbal tea | |
JP3945573B2 (en) | How to adjust herbal tea and taste | |
RU2174005C1 (en) | Species of medicinal herbs for treatment of neuroses and neurasthenia | |
CH714889B1 (en) | Herbal mixture for making beverages, foodstuffs or semi-luxury foods. | |
CN110545830A (en) | Composition for topical use comprising essential oils | |
RU2160596C1 (en) | Medicinal plants species possessing antiviral, antimicrobial and immunomodulation activity | |
RU2176895C2 (en) | Biologically active supplement and method of enhancement of human mental and physical working capacity | |
KR20230164488A (en) | Cheongmo tea composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130114 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20140123 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20150116 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20161228 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20171222 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20190102 Year of fee payment: 17 |